0001989984-23-000001.txt : 20230815 0001989984-23-000001.hdr.sgml : 20230815 20230815152555 ACCESSION NUMBER: 0001989984-23-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20230815 DATE AS OF CHANGE: 20230815 EFFECTIVENESS DATE: 20230815 FILER: COMPANY DATA: COMPANY CONFORMED NAME: VIN-41 Neurexis Therapeutics, LLC CENTRAL INDEX KEY: 0001989984 IRS NUMBER: 932143409 STATE OF INCORPORATION: AR FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-489806 FILM NUMBER: 231174635 BUSINESS ADDRESS: STREET 1: 535 W. RESEARCH CENTER BLVD STREET 2: SUITE 135 CITY: FAYETTEVILLE STATE: AR ZIP: 72701 BUSINESS PHONE: 479-571-2592 MAIL ADDRESS: STREET 1: 535 W. RESEARCH CENTER BLVD STREET 2: SUITE 135 CITY: FAYETTEVILLE STATE: AR ZIP: 72701 D 1 primary_doc.xml X0708 D LIVE 0001989984 VIN-41 Neurexis Therapeutics, LLC 535 W. RESEARCH CENTER BLVD SUITE 135 FAYETTEVILLE AR ARKANSAS 72701 479-571-2592 ARKANSAS None None Limited Liability Company true 2023 Robert Calvin Goforth 535 W. Research Center Blvd Suite 135 Fayetteville AR ARKANSAS 72701 Executive Officer CEO of VIC Technology Venture Development, LLC, Sole Manager Mark Wagstaff 535 W. Research Center Blvd Suite 135 Fayetteville AR ARKANSAS 72701 Executive Officer Secretary and Treasurer Other Decline to Disclose 06b false 2023-08-02 false true false 5000 500000 20000 480000 false 2 0 0 0 false VIN-41 Neurexis Therapeutics, LLC /s/ Robert Calvin Goforth Robert Calvin Goforth CEO of VIC Technology Venture Development, LLC, Sole Manager 2023-08-15